Gordon Paul H, Yu Qiping, Qualls Clifford, Winfield Hal, Dillon Sandra, Greene Paul E, Fahn Stanley, Breeze Robert E, Freed Curt R, Pullman Seth L
Department of Neurology and Clinical Motor Physiology Laboratory, Columbia-Presbyterian Medical Center, New York, NY 10032, USA.
Arch Neurol. 2004 Jun;61(6):858-61. doi: 10.1001/archneur.61.6.858.
Embryonic nigral cell implants are a novel treatment for Parkinson disease (PD). Reaction time (RT) and movement time (MT) analysis, validated quantitative measures of premovement neural processing and motor execution, can be used as objective physiological markers of motor performance in PD.
To gauge the change in motor performance in patients with PD who received implants, and to determine whether the physiological findings correlate with clinical outcome measures after transplantation.
Double-blind, placebo-controlled trial. Patients Forty patients with levodopa-responsive, Hoehn and Yahr stage III or greater PD.
Random assignment to embryonic tissue implants or placebo (sham) operation.
Combined RT + MT scores measured preoperatively and at 4 and 12 months postoperatively in the "off" state.
The difference in mean RT + MT scores between the sham and implant groups was statistically significant (P =.005) and was greatest in those 60 years or older (P =.003). Changes correlated with Unified Parkinson's Disease Rating Scale off scores at 4 (r = 0.87, P =.001) and 12 (r = 0.75, P =.01) months in those younger than 60 years. There was a significant deterioration in the sham surgery group at 12 months (P =.03) that was thought to be due to worsening in subjects 60 years and older (P<.001).
The physiological measures detected significant changes in patients undergoing embryonic nigral cell implants and correlated directly with clinical outcome measures. Comprehensive analyses of RT paradigms can document subtle changes in motor performance over time, making them useful outcome measures in therapeutic trials of PD. These findings support further research into nigral cell implantation for PD.
胚胎黑质细胞植入是治疗帕金森病(PD)的一种新方法。反应时间(RT)和运动时间(MT)分析是对运动前神经加工和运动执行的有效定量测量,可作为PD运动表现的客观生理指标。
评估接受植入治疗的PD患者运动表现的变化,并确定生理结果与移植后临床结局指标是否相关。
双盲、安慰剂对照试验。
40例对左旋多巴有反应、Hoehn和Yahr分期为III期或更高的PD患者。
随机分配接受胚胎组织植入或安慰剂(假)手术。
在“关”状态下术前、术后4个月和12个月测量的RT + MT综合评分。
假手术组和植入组的平均RT + MT评分差异有统计学意义(P = 0.005),在60岁及以上患者中差异最大(P = 0.003)。60岁以下患者在4个月(r = 0.87,P = 0.001)和12个月(r = 0.75,P = 0.01)时,变化与帕金森病统一评分量表的“关”期评分相关。假手术组在12个月时出现显著恶化(P = 0.03),被认为是由于60岁及以上患者病情恶化所致(P<0.001)。
生理测量发现接受胚胎黑质细胞植入的患者有显著变化,且与临床结局指标直接相关。对RT范式的综合分析可以记录运动表现随时间的细微变化,使其成为PD治疗试验中有用的结局指标。这些发现支持对PD黑质细胞植入进行进一步研究。